RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.11
-0.10 (-1.22%)
At close: Oct 9, 2025, 4:00 PM EDT
8.12
+0.01 (0.12%)
After-hours: Oct 9, 2025, 7:28 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $331.83 million as of October 9, 2025. Its market cap has decreased by -82.90% in one year.
Market Cap
331.83M
Enterprise Value
116.05M
1-Year Change
-82.90%
Ranking
Category
Stock Price
$8.11
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $331.83M, a decrease of -21.80%. That is a compound annual growth rate of -5.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 331.83M | -76.05% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |